Holen Sie sich die Stockscreener-App
29.31
3.43%
-1.04
Handel nachbörslich:
29.00
-0.31
-1.06%
Schlusskurs vom Vortag:
$30.35
Offen:
$30.7
24-Stunden-Volumen:
538.98K
Relative Volume:
1.21
Marktkapitalisierung:
$1.56B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-18.20
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
+9.41%
1M Leistung:
+32.50%
6M Leistung:
+187.07%
1J Leistung:
+83.53%
1-Tages-Spanne:
$29.03
$30.70
1-Wochen-Bereich:
$24.95
$30.70
52-Wochen-Spanne:
$6.42
$30.70
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
29.31 | 1.62B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Is Tyra Biosciences Inc. stock a dividend growth opportunity2025 Key Lessons & Weekly High Return Forecasts - ulpravda.ru
Tyra Biosciences stock hits 52-week high at $30.27 By Investing.com - Investing.com India
How Tyra Biosciences Inc. stock reacts to global recession fearsPortfolio Risk Summary & AI Driven Stock Reports - ulpravda.ru
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month HighHere's Why - MarketBeat
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Promising Growth Stocks To Follow Now – January 5th - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Down 6%What's Next? - MarketBeat
Is Tyra Biosciences Inc a good long term investmentInsider Selling Patterns & Fast Growing Investment Ideas - earlytimes.in
Tyra Biosciences (NASDAQ:TYRA) Rating Increased to Hold at Wall Street Zen - Defense World
(TYRA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 25% Upside Potential in the Biotech Space - DirectorsTalk Interviews
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year High – Still a Buy? - Defense World
Tyra Biosciences stock hits 52-week high at $26.36 By Investing.com - Investing.com Nigeria
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Tyra Biosciences stock hits 52-week high at $26.36 - Investing.com
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $37 - 富途牛牛
Is Tyra Biosciences Inc. stock gaining market shareMACD Histogram Signals & Start Learning With Our Courses - bollywoodhelpline.com
Tyra Biosciences (NASDAQ:TYRA) Cut to Sell at Wall Street Zen - Defense World
Tyra Biosciences Reports Increased Loss Amid R&D Investments - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week HighHere's What Happened - MarketBeat
Does Tyra Biosciences (TYRA) Index Inclusion Mark a Turning Point in Its Institutional Story? - Yahoo Finance
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally - Yahoo Finance
(TYRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tyra Biosciences director more sells $250k in shares By Investing.com - Investing.com South Africa
Tyra Biosciences director more sells $250k in shares - Investing.com
Tyra Biosciences, Inc.(NasdaqGS: TYRA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Will Tyra Biosciences Inc. stock remain a Wall Street favorite2025 Winners & Losers & AI Powered Trade Plan Recommendations - Улправда
Tyra Biosciences (TYRA) Is Up 12.7% After Wedbush Highlights Pipeline Momentum And Leadership RefreshWhat's Changed - Sahm
Tyra Biosciences (NASDAQ:TYRA) Director Sells $250,000.00 in Stock - MarketBeat
Chmn More Sells 10,000 ($250K) Of Tyra Biosciences Inc [TYRA] - TradingView — Track All Markets
Can Tyra Biosciences Inc. stock surprise with earnings upsideJuly 2025 Patterns & Fast Exit and Entry Trade Guides - Улправда
Tyra Biosciences stock hits 52-week high at 24.05 USD By Investing.com - Investing.com Nigeria
Tyra Biosciences (NASDAQ:TYRA) Sets New 52-Week HighHere's What Happened - MarketBeat
Tyra Biosciences stock hits 52-week high at 24.05 USD - Investing.com
Why Tyra Biosciences Inc. stock attracts high net worth investorsForecast Cut & Daily Profit Focused Stock Screening - Улправда
Growth Recap: Will Tyra Biosciences Inc. stock remain a Wall Street favoriteMarket Activity Summary & Low Risk Entry Point Guides - Улправда
Tyra Biosciences' Chief Discovery Officer Sells 8,000 Shares - TradingView — Track All Markets
Tyra Biosciences (TYRA) insider sells 8,000 shares in planned trade - Stock Titan
Accenture To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Wedbush raises Tyra Biosciences stock price target to $37 on pipeline potential - Investing.com Canada
Assessing Tyra Biosciences (TYRA) Valuation Following Key Executive Hires to Support Advancing Clinical Pipeline - Sahm
Officer Bensen Files To Sell 8,000 Of Tyra Biosciences Inc [TYRA] - TradingView — Track All Markets
Understanding the Setup: (TYRA) and Scalable Risk - Stock Traders Daily
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tyra Biosciences Inc-Aktie (TYRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bensen Daniel | Chief Discovery Officer |
Dec 12 '25 |
Sale |
22.64 |
8,000 |
181,159 |
162,981 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):